Scegli un formato
| A voi/SKU | Disponibilità | Prezzo |
|---|---|---|
10 μg | Per informazioni sulla disponibilità, contatta il Servizio Clienti. | 516,00 € |
Informazioni su questo articolo
516,00 €
Nome del prodotto
Bone Morphogenetic Protein 4 human, >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, suitable for cell culture
biological source
human
Quality Segment
recombinant
expressed in NSO cells
assay
>95% (SDS-PAGE)
form
lyophilized powder
potency
0.70-7.00 ng/mL ED50
mol wt
monomer calculated mol wt 13 kDa, ~22 kDa by SDS-PAGE
packaging
pkg of 10 μg
storage condition
avoid repeated freeze/thaw cycles (Do not store in a frost-free freezer.)
technique(s)
cell culture | mammalian: suitable
impurities
<0.01 EU/μg Endotoxin level (LAL test)
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... BMP4(652)
Biochem/physiol Actions
Physical form
Analysis Note
1 of 1
Questo articolo | |||
|---|---|---|---|
| biological source human | biological source human | biological source human | biological source human |
| assay >95% (SDS-PAGE) | assay ≥98% (SDS-PAGE) | assay ≥98% (SDS-PAGE) | assay ≥95% (SDS-PAGE) |
| recombinant expressed in NSO cells | recombinant expressed in E. coli | recombinant expressed in E. coli | recombinant expressed in HEK 293 cells |
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level - |
| form lyophilized powder | form lyophilized powder | form lyophilized powder | form lyophilized |
Still not finding the right product?
Explore all of our products under Bone Morphogenetic Protein 4 human
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

